Table 1

Clinical data for groups stratified by telomere maintenance phenotypes (n = 60)a

TA−/ALT+TA+/ALT−TA+/ALT+TA−/ALT−Total
No. of patients2111171160
Sex
 Male1357429
 Female8610731
Age (median, yr)2124222121.5
Tumor location
 Extremities209161055
 Pelvis12115
Stage
 Localized199141052
 Metastatic22318
Chemotherapy response
 ≥90% necrosis524112
 <90% necrosis1368835
 Not determined335213
  • a Two patients in whom there was acquisition of a TMM between the primary tumor and the metastatic tumor are not included (see “Results”).